Icatibant
Icatibant is a selective and specific antagonist of bradykinin B2 receptor with IC50 and Ki of 1.07 nM and 0.798 nM respectively.
| Trivial name | HOE140 |
| Catalog Number | CSN11154 |
| Alternative Name(s) | HOE140 |
| Research Area | / |
| Molecular Formula | C59H89N19O13S |
| CAS# | 130308-48-4 |
| Purity | ≥98% |
| SMILES | [H][C@]1(C[C@@H](C(N[C@H](C(O)=O)CCCNC(N)=N)=O)N2C([C@@H]3N(C([C@H](CO)NC([C@H](CC4=CC=CS4)NC(CNC([C@@H]5C[C@@H](O)CN5C([C@H]6N(C([C@H](CCCNC(N)=N)NC([C@H](N)CCCNC(N)=N)=O)=O)CCC6)=O)=O)=O)=O)=O)CC7=C(C=CC=C7)C3)=O)[C@]2([H])CCCC1 |
| Size | 5mg |
| Supplier Page | https://www.csnpharm.com/products/icatibant.html |